The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 25, 2018

Filed:

Apr. 05, 2017
Applicant:

Virginia Commonwealth University, Richmond, VA (US);

Inventors:

Ruey-min Lee, Short Hills, NJ (US);

Peck-sun Lin, Richmond, VA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/53 (2006.01); A61K 31/167 (2006.01); A61K 39/395 (2006.01); C07K 16/22 (2006.01); A61K 31/135 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 47/46 (2006.01);
U.S. Cl.
CPC ...
A61K 31/53 (2013.01); A61K 9/0019 (2013.01); A61K 31/135 (2013.01); A61K 31/167 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/46 (2013.01); C07K 16/22 (2013.01); C07K 2317/24 (2013.01);
Abstract

Methods and compositions for enhancing the ability of hypoxia-activated bioreductive agents to kill tumor cells within solid tumors are provided. Local regions of hypoxia are created within a tumor, or within a region containing a tumor, resulting in enhanced activation of hypoxia-activated bioreductive agents (e.g. tirapazamine) within the local region. The activated hypoxia-activated bioreductive agents kill tumor cells in the hypoxic region by catalyzing DNA stand breakage within the tumor cells. Because the activity is localized, side effects that typically occur as a result of systemic administration of bioreductive agents are reduced.


Find Patent Forward Citations

Loading…